glp-1 agonist Receptor Agonists and Research to Treat Overeating and Substance Use Disorders Video: Non-insulin injectable antidiabetic drugs
Description
The TRIUMPH program enrolled more than 5,800 participants across multiple registrational trials evaluating retatrutide across obesity, obstructive sleep apnoea, and knee osteoarthritis comorbidities
Only for diabetes, obstructive sleep apnea (Zepbound), or cardiovascular and MASH indications (Wegovy)
Many countries factor WHO guidelines into their health policies
About this article Cite this article Sheth, K., Kim, S., Porterfield, L
The most well-known tirzepatide brands are Mounjaro and Zepbound
